Health Care: Drugs

Emergent BioSolutions Inc (EBS: NYSE)

$21.6 n/a | n/a%
10/23/14 - 04:01 PM ET
Company Income Statement
Dec 2013 Dec 2012 Dec 2011 Dec 2010
Sales 312.74M 281.89M 273.38M 286.17M
Cost of Sales 43.17M 34.88M 32.82M 41.12M
Gross Operating Profit 269.58M 247.01M 240.57M 245.05M
Selling, General, and Administrative Expenses 87.88M 76.02M 74.28M 76.20M
Research & Development 119.93M 120.23M 124.83M 89.30M
Operating Income before D & A (EBITDA) 61.76M 50.76M 41.45M 79.55M
Depreciation & Amortization 18.96M 11.20M 9.36M 5.99M
Interest Income 139.00K 134.00K 105.00K 832.00K
Other Income - Net 426.00K 1.97M -261.00K -1.02M
Special Income / Charges 0.00 -9.60M 0.00 0.00
Total Income Before Interest Expenses (EBIT) 43.37M 32.07M 31.94M 73.37M
Interest Expense 0.00 6.00K 0.00 0.00
Pre-Tax Income 43.37M 32.06M 31.94M 73.37M
Income Taxes 13.11M 13.92M 15.83M 26.18M
Minority Interest -876.00K -5.38M -6.91M -4.51M
Net Income From Continuing Operations 30.26M 18.14M 16.11M 47.18M
Net Income From Discontinued Operations 0.00 0.00 0.00 0.00
Net Income From Total Operations 30.26M 18.14M 16.11M 47.18M
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income 31.14M 23.52M 23.02M 51.70M
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
30.26M 27.74M 16.11M 47.18M
Preferred Dividends
Net Income Available To Common 30.26M 18.14M 16.11M 47.18M
Basic EPS from Continuing Ops. 0.86 0.65 0.65 1.63
Basic EPS from Discontinued Ops. 0.00 0.00 0.00 0.00
Basic EPS from Total Operations 0.86 0.65 0.65 1.63
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.00
Basic EPS, Total 0.86 0.65 0.65 1.63
Basic Normalized Net Income/Share 0.86 1.00 0.65 1.63
EPS fr Continuing Ops. 0.85 0.65 0.64 1.59
EPS fr Discontinued Ops 0.00 0.00 0.00 0.00
EPS fr Total Ops. 0.85 0.65 0.64 1.59
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.00 0.00
EPS, Total 0.85 0.65 0.64 1.59
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
0.85 0.99 0.64 1.59
Dividends Paid per Share 0.00 0.00 0.00 0.00

Portfolios with EBS

Latest EBS Headlines from TheStreet

More Financial News for EBS

Press Releases for EBS

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter